Indeed, we reported that the combination of ABT-737 and Nutlin [25] and of ABT-199 and the MDM2 inhibitor RG-7388 [26] synergistically induce apoptosis in AML cell lines and primary patient cells and overcome inherent or acquired resistance to ABT-199. Here, MDM2 is linked to acute myeloid leukemia.